Top Markets
#1 Pleasing Gold Pleasing Gold +1,551.64%
#2 PulseChain PulseChain +57.52%
#3 DogBull DogBull +36.66%
#4 Ontology Gas Ontology Gas +36.38%
#5 Merlin's Seal BTC Merlin's Seal BTC +31.50%
#6 BOOK OF MEME BOOK OF MEME +30.63%
#7 Collect on Fanable Collect on Fanable +23.59%
#8 Neiro Neiro +20.95%
#9 Nockchain Nockchain +19.81%
#10 Unit Pump Unit Pump +19.05%
Coin of the day
Pleasing Gold Pleasing Gold
सेटिंग्स
भाषा
हिन्दी
मुद्रा
USD
थीम
PharmAust Limited PharmAust Limited

PharmAust Limited

PAA
शेयरों में रैंक #26700
Operating internationally, including in Switzerland, Australia, Sweden, and the... Operating internationally, including in Switzerland, Australia, Sweden, and the United States, PharmAust Limited specializes in developing targeted cancer treatments for both human and animal applications. The company also cultivates intellectual property in drug discovery, addressing a range of cancers and neurological conditions. Its primary therapeutic candidate is Monepantel (MPL), a small molecule compound currently undergoing Phase II clinical trials for cancer treatment. Beyond its drug development pipeline, PharmAust provides synthetic and medicinal chemistry products and expert services to the global drug discovery and pharmaceutical sectors. The firm also holds a research agreement with the Walter and Eliza Hall Institute, investigating in vitro the effects of MPL on human T-lymphotrophic virus-1 (HTLV-1) infections. Established in 2000, PharmAust Limited is headquartered in Bentley, Australia.
शेयर मूल्य
$0.12164306
अंतिम समन्वयन: 2024-11-11
मार्केट कैप
$38.53M
बदलाव (1 दिन)
-4.14%
बदलाव (1 वर्ष)
0.00%
देश
AU
व्यापार PharmAust Limited (PAA)

श्रेणी

Healthcare
PharmAust Limited (PAA) के लिए राजस्व
Jun 2024 में राजस्व TTM: $572.45K
PharmAust Limited की नवीनतम वित्तीय रिपोर्टों के अनुसार, कंपनी की वर्तमान राजस्व (TTM) $572.45K है। 2023 में, कंपनी ने $1.88M का राजस्व अर्जित किया जो 2022 के $2.33M के राजस्व से की तुलना में कमी है। राजस्व वह कुल आय है जो कंपनी अपने उत्पादों या सेवाओं की बिक्री से उत्पन्न करती है। लाभ की तुलना में इसमें कोई खर्च घटाया नहीं जाता।
PharmAust Limited के लिए 2001 से 2026 तक की राजस्व इतिहास
प्रत्येक वर्ष के अंत में राजस्व
वर्ष राजस्व परिवर्तन
2026 (TTM) $572.45K 0.00%
2024 0.00 -100.00%
2023 $1.88M -19.32%
2022 $2.33M 45.33%
2021 $1.60M -27.22%
2020 $2.21M -27.76%
2019 $3.05M 26.47%
2018 $2.41M -5.23%
2017 $2.55M 25.80%
2016 $2.02M 10.90%
2015 $1.83M -0.20%
2014 $1.83M 17.05%
2013 $1.56M -5.48%
2012 $1.65M -0.67%
2011 $1.66M 19.79%
2010 $1.39M -2.17%
2009 $1.42M -47.01%
2008 $2.68M -55.73%
2007 $6.05M 33.53%
2006 $4.53M 85.63%
2005 $2.44M 1,047.74%
2004 $212.83K 366.98%
2003 $45.58K -88.07%
2002 $381.98K 0.00%
2001 0.00 0.00%
समान कंपनियों या प्रतिस्पर्धियों के लिए राजस्व
कंपनी राजस्व राजस्व में अंतर देश
Vertex Pharmaceuticals Incorporated Vertex Pharmaceuticals Incorporated
Vertex Pharmaceuticals Incorporated
VRTX.US
 $12.62B 2,205,224.96%
US
Argenx SE Argenx SE
Argenx SE
ARGX.US
 $6.02B 1,051,752.00%
NL
CSL Limited CSL Limited
CSL Limited
CSL.AX
 $15.70B 2,741,683.32%
AU
Moderna, Inc. Moderna, Inc.
Moderna, Inc.
MRNA.US
 $2.23B 389,106.85%
US
Lonza Group AG Lonza Group AG
Lonza Group AG
LONN.SW
 - -
CH